Remote Jobs at Syncromune®
Syncromune®
51 - 200 employees
Founded 2020
🧬 Biotechnology
💊 Pharmaceuticals
🏥 Healthcare
💰 $111.8M Series A - Syncromune on 2024-12
Biotechnology • Pharmaceuticals • Healthcare
Syncromune is a clinical-stage company developing a novel intratumoral cancer immunotherapy platform called SYNC-T. The platform is designed to be delivered directly into target tumors to synchronize the immune system to recognize and destroy cancer throughout the body. Its lead investigational therapy, SV-102, is being evaluated in the LEGION-100 Phase 2 trial for metastatic castration-resistant prostate cancer. The company’s materials are directed at healthcare professionals and note that its compounds are investigational and not yet approved by regulatory authorities.
📡 We watch Syncromune®'s careers page
Several times a day
how often we check
0
roles posted in the last 30 days
4
roles closed in the last year
Selected: 🇺🇸 United States – Remote USA.
Is on LinkedIn?
